LAUSANNE, Switzerland, April 11, 2019 /PRNewswire/ -- SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight against cancer. This standardized molecular diagnostic application precisely detects and characterizes all types of genomic alterations Read more...
TEL AVIV, Israel, Feb. 27, 2020 /PRNewswire/ -- Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powered cancer diagnostics, today announced CE-IVD Mark for the Galen™ Prostate solution for use in supporting pathologists in identification of suspected can Read more...
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a high throughput chemiluminescent immunoassay with excellent correlation to a fluorescence based neutralization assay, which has been used to evaluate the adaptive immune response i Read more...
